News | Breast Imaging | May 17, 2016

Move follows $40 million financing round, expansion of management team

Delphinus Medical Technologies, headquarters relocate, Novi Michigan, SoftVue breast ultrasound

May 17, 2016 — Advanced breast ultrasound technology provider Delphinus Medical Technologies Inc. announced it is relocating its corporate headquarters from Plymouth Township, Mich., to Novi, Mich. in mid-May.

The new headquarters is nearly triple the size of its prior location, growing from 7,500 to 21,000 square feet. This will allow Delphinus to expand its staff, dedicate more space to research and development, and prepare for commercialization of SoftVue, a whole breast ultrasound system that allows physicians to image the entire breast for diagnostic imaging purposes.

The expansion is the latest in a recent series of achievements for the company. In December 2015, on the heels of a Series C venture round of $40 million, Delphinus added two new senior-level advisors to its board of directors, as well as a new vice president of quality and regulatory affairs.

One of the additions to the new facility will be a dedicated demonstration room that will allow the company to showcase SoftVue and image review to site visitors.

As an ultrasound technology, SoftVue offers the potential to not only assist physicians in finding more cancers, but also to reduce the false-positive rates that have troubled other breast imaging techniques. SoftVue’s design incorporates a circular ultrasound transducer featuring proprietary TriAD (triple acoustic detection) technology. This multi-dimensional advancement presents cross-sectional ultrasound slices through the entire volume of breast tissue, capturing not only reflected echoes in a 360-degree array, but also signals passing through the breast, depicting tissue characterization.

SoftVue is indicated for use as a B-mode ultrasonic imaging system and is not intended to be used as a replacement for screening mammography.

For more information: www.delphinusmt.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
Subscribe Now